JUNS stock

Jupiter Neurosciences, Inc. Common Stock (JUNS) financials · rev $21.8K

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Jupiter Neurosciences, Inc. Common Stock (JUNS) rev $21.8K.

Cached annual income statement
LineFY2025FY2024
Revenue$21.8KN/A
Cost of Revenue$4.23KN/A
Gross Profit$17.6KN/A
Operating Income-$8.91M-$3.09M
Net Income-$8.64M-$2.44M
EPS (Diluted)N/AN/A
Cached annual balance sheet
LineFY2025FY2024
Total Assets$5.56M$6.20M
Current Assets$4.82M$4.65M
Cash & Equivalents$3.79M$3.77M
Inventory$159.8KN/A
Total Liabilities$7.40M$2.03M
Current Liabilities$7.40M$2.01M
Shareholders' Equity-$1.83M$4.17M
Retained Earnings-$34.7M-$26.0M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$5.41M-$3.91M
Financing Cash Flow$5.43M$7.65M
Net Change in Cash$19.8K$3.74M
These statements as JSON? API free 100/day

FAQ

What is JUNS P/E and revenue?

Jupiter Neurosciences, Inc. Common Stock (JUNS) rev $21.8K.

What is JUNS revenue?

Jupiter Neurosciences, Inc. Common Stock last cached revenue is $21.8K (FY2025).

Is JUNS profitable?

Jupiter Neurosciences, Inc. Common Stock last cached net income is -$8.64M (FY2025).

What are JUNS total assets?

Jupiter Neurosciences, Inc. Common Stock last cached total assets are $5.56M (FY2025).

What is JUNS free cash flow?

No cached cash-flow row for JUNS yet.

Not investment advice. Cached statements, not a live tape.